The present invention is directed to novel pyrazolopyrimidines, their derivatives, pharmaceutically acceptable salts, solvates and hydrates thereof. The compounds and compositions of the present invention have protein kinases inhibitory activities against BTK and/or EGFR T790M and are useful for the treatment of protein kinases mediated diseases and conditions.
本发明涉及新型的
吡唑吡咯啉及其衍
生物、药学上可接受的盐、溶剂和
水合物。本发明的化合物和组合物具有对BTK和/或
EGFR T790M的蛋白激酶抑制活性,并可用于治疗蛋白激酶介导的疾病和病况。